My research focuses on identifying pathologic, immunohistochemical, and genetic markers that will improve the classification of lung cancer, provide predictive information regarding therapy, and provide more precise prognostic information. With the advent of high throughput next generation sequencing technologies, I am engaged in translation of novel observations surrounding tumor biology into clinical diagnostics and have a special interest in understanding the genomic modifiers of tumor behavior, morphology, and response to treatment.